Stay updated on Efficacy of ATB-346 in Osteoarthritis Patients Clinical Trial
Sign up to get notified when there's something new on the Efficacy of ATB-346 in Osteoarthritis Patients Clinical Trial page.

Latest updates to the Efficacy of ATB-346 in Osteoarthritis Patients Clinical Trial page
- Check6 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check13 days agoChange DetectedThe two screenshots show the same study details page with no substantive differences in arms, outcomes, eligibility, or locations.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior items (the funding-status notice and Revision: v3.4.1). This is a minor platform update that does not alter the study details.SummaryDifference0.3%

- Check41 days agoChange DetectedA government funding lapse notice was added and the site revision updated to v3.4.1, replacing v3.4.0.SummaryDifference0.3%

- Check48 days agoChange DetectedAdded a 'Show glossary' option and minor label capitalization tweaks (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data') and updated the page revision to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check84 days agoChange DetectedAdded a consolidated Locations section listing Canadian sites by province (British Columbia, Nova Scotia, Ontario, Quebec) and updated the page revision to v3.3.3; the separate provincial location sections were removed.SummaryDifference0.4%

Stay in the know with updates to Efficacy of ATB-346 in Osteoarthritis Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of ATB-346 in Osteoarthritis Patients Clinical Trial page.